These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28159404)

  • 1. [PD1/PD-L1 immunohistochemistry in thoracic oncology: Where are we?].
    Hofman P; Ilié M; Lassalle S; Long E; Bence C; Butori C; Hofman V
    Ann Pathol; 2017 Feb; 37(1):39-45. PubMed ID: 28159404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].
    Duruisseaux M; Rouquette I; Adam J; Cortot A; Cazes A; Gibault L; Damotte D; Lantuejoul S
    Ann Pathol; 2017 Feb; 37(1):61-78. PubMed ID: 28162296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].
    Lantuejoul S; Adam J; Girard N; Duruisseaux M; Mansuet-Lupo A; Cazes A; Rouquette I; Gibault L; Garcia S; Antoine M; Vignaud JM; Galateau-Sallé F; Sagan C; Badoual C; Penault-Llorca F; Damotte D;
    Ann Pathol; 2018 Apr; 38(2):110-125. PubMed ID: 29571563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?
    Hofman P
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1097-1108. PubMed ID: 29069958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive biomarkers of efficacy of checkpoint blockade inhibitors in cancer treatment].
    Duruisseaux M; Lize-Dufranc C; Badoual C; Bibeau F
    Ann Pathol; 2017 Feb; 37(1):46-54. PubMed ID: 28131419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma].
    Adam J; Tomasic G; Robert C
    Ann Pathol; 2017 Feb; 37(1):55-60. PubMed ID: 28111041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of PD-L1 bioassays for cancer immunotherapy.
    Liu D; Wang S; Bindeman W
    J Hematol Oncol; 2017 May; 10(1):110. PubMed ID: 28514966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28-8 and E1L3N).
    Ma J; Li J; Qian M; Han W; Tian M; Li Z; Wang Z; He S; Wu K
    Diagn Pathol; 2018 Nov; 13(1):91. PubMed ID: 30463584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.
    Sholl LM; Aisner DL; Allen TC; Beasley MB; Borczuk AC; Cagle PT; Capelozzi V; Dacic S; Hariri L; Kerr KM; Lantuejoul S; Mino-Kenudson M; Raparia K; Rekhtman N; Roy-Chowdhuri S; Thunnissen E; Tsao MS; Yatabe Y;
    Arch Pathol Lab Med; 2016 Apr; 140(4):341-4. PubMed ID: 26780537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy.
    Villaruz LC; Socinski MA
    Clin Pharmacol Ther; 2016 Sep; 100(3):212-4. PubMed ID: 27090296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.
    Reis H; Serrette R; Posada J; Lu V; Chen YB; Gopalan A; Fine SW; Tickoo SK; Sirintrapun SJ; Iyer G; Funt SA; Teo MY; Rosenberg JE; Bajorin DF; Dalbagni G; Bochner BH; Solit DB; Reuter VE; Al-Ahmadie HA
    Am J Surg Pathol; 2019 Jul; 43(7):920-927. PubMed ID: 31135485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms.
    Giunchi F; Gevaert T; Scarpelli M; Fiorentino M
    Curr Drug Targets; 2020; 21(13):1286-1292. PubMed ID: 31971109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma.
    Gabrych A; Pęksa R; Kunc M; Krawczyk M; Izycka-Swieszewska E; Biernat W; Bień E
    Pathol Res Pract; 2019 Dec; 215(12):152700. PubMed ID: 31704149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti-PD-1/PD-L1 therapy.
    Roberts JA; Gonzalez RS; Das S; Berlin J; Shi C
    Hum Pathol; 2017 Dec; 70():49-54. PubMed ID: 29037958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of programmed death ligand (PD-L1) in different tumors. Comparison of several current available antibody clones and antibody profiling.
    Kintsler S; Cassataro MA; Drosch M; Holenya P; Knuechel R; Braunschweig T
    Ann Diagn Pathol; 2019 Aug; 41():24-37. PubMed ID: 31132649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.
    Udall M; Rizzo M; Kenny J; Doherty J; Dahm S; Robbins P; Faulkner E
    Diagn Pathol; 2018 Feb; 13(1):12. PubMed ID: 29426340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PD-L1 expression: An emerging biomarker in non-small cell lung cancer].
    Adam J; Planchard D; Marabelle A; Soria JC; Scoazec JY; Lantuéjoul S
    Ann Pathol; 2016 Jan; 36(1):94-102. PubMed ID: 26778219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune-checkpoint and hemopathies].
    Burroni B; Broudin C; Damotte D; Laurent C
    Ann Pathol; 2017 Feb; 37(1):101-110. PubMed ID: 28161001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma.
    Mitteldorf C; Berisha A; Tronnier M; Pfaltz MC; Kempf W
    J Cutan Pathol; 2017 Sep; 44(9):740-746. PubMed ID: 28569410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies around PD-L1 testing in France].
    Penault-Llorca F
    Ann Pathol; 2017 Feb; 37(1):3-4. PubMed ID: 28108043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.